Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Abbott Laboratories stock price, quote, forecast and news

ABT
US0028241000
850103

Price

103.72 USD
Today +/-
+0 USD
Today %
+0 %
P

Abbott Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Abbott Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Abbott Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Abbott Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Abbott Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Abbott Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Abbott Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Abbott Laboratories’s growth potential.

Abbott Laboratories Revenue, EBIT and net profit per share

DateAbbott Laboratories RevenueAbbott Laboratories EBITAbbott Laboratories Net Income
2029e61.91 B USD0 USD13.62 B USD
2028e54.95 B USD13.82 B USD11.53 B USD
2027e51.46 B USD12.64 B USD10.67 B USD
2026e48.54 B USD11.62 B USD9.99 B USD
2025e45.23 B USD10.52 B USD9.03 B USD
2024e42.16 B USD9.43 B USD8.13 B USD
202340.11 B USD6.72 B USD5.72 B USD
202243.65 B USD8.71 B USD6.93 B USD
202143.08 B USD8.59 B USD7.07 B USD
202034.61 B USD5.43 B USD4.5 B USD
201931.9 B USD4.67 B USD3.69 B USD
201830.58 B USD3.73 B USD2.37 B USD
201727.39 B USD1.87 B USD477 M USD
201620.85 B USD3.06 B USD1.4 B USD
201520.41 B USD2.96 B USD4.42 B USD
201420.25 B USD2.76 B USD2.28 B USD
201319.66 B USD2.13 B USD2.58 B USD
201219.05 B USD1.36 B USD5.96 B USD
201121.41 B USD1.59 B USD4.73 B USD
201035.17 B USD6.46 B USD4.63 B USD
200930.77 B USD6.61 B USD5.75 B USD
200829.53 B USD5.83 B USD4.88 B USD
200725.91 B USD4.58 B USD3.61 B USD
200622.48 B USD4.06 B USD1.72 B USD
200522.34 B USD4.38 B USD3.37 B USD
200419.68 B USD4.18 B USD3.24 B USD

Abbott Laboratories Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B USD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B USD)EBIT (B USD)EBIT MARGIN (%)NET INCOME (B USD)NET INCOME GROWTH (%)DIV. (USD)DIV. GROWTH (%)SHARES (B)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
2.933.13.363.814.394.945.386.166.887.858.419.1610.0111.0111.8912.5113.1813.7516.2915.2817.2819.6822.3422.4825.9129.5330.7735.1721.4119.0519.6620.2520.4120.8527.3930.5831.934.6143.0843.6540.1142.1645.2348.5451.4654.9561.91
-6.018.2513.3315.2312.518.9714.4811.6614.187.088.909.3510.007.955.255.314.3118.47-6.1713.0913.8913.510.6215.3013.954.1914.31-39.13-11.013.193.000.782.2031.3511.644.348.4824.471.34-8.125.117.287.336.016.7812.67
48.1649.5849.5550.9252.1052.3452.4752.7554.3455.3656.1756.3856.7957.0357.5156.7954.6454.6152.4255.3655.0154.8652.3656.3355.9257.2957.0658.3053.0053.2953.2354.5757.2256.4354.7458.5058.6456.7557.0756.2855.32------
1.411.541.671.942.292.582.823.253.744.354.725.165.696.286.847.117.27.518.548.469.5110.811.712.6614.4916.9217.5620.511.3510.1510.4611.0511.6811.7714.9917.8918.7119.6424.5924.5722.19000000
0.60.680.740.881.011.11.221.411.561.531.922.142.382.622.833.123.153.263.223.263.074.184.384.064.585.836.616.461.591.362.132.762.963.061.873.734.675.438.598.716.729.4310.5211.6212.6413.820
20.6321.8121.9323.0822.9322.3222.7022.8322.6419.4322.8823.4223.8023.7623.8424.9223.9023.7319.8021.3417.7921.2219.6018.0517.6719.7321.4818.367.407.1410.8513.6514.5214.666.8312.2014.6415.6919.9419.9516.7622.3623.2523.9424.5725.16-
0.350.40.470.540.630.750.860.971.091.241.41.521.691.882.082.332.452.791.552.792.753.243.371.723.614.885.754.634.735.962.582.284.421.40.482.373.694.57.076.935.728.139.039.9910.6711.5313.62
-15.8015.3816.1317.2218.8014.3612.3312.7313.7712.918.4311.3411.4310.4712.274.8013.90-44.3680.26-1.4717.544.20-49.08110.0235.3617.72-19.492.2026.12-56.80-11.3493.65-68.35-65.93396.4455.7021.9157.31-1.95-17.4542.0811.0910.636.728.1518.05
-----------------------------------------------
-----------------------------------------------
1.951.931.921.871.821.811.791.741.711.691.661.621.611.581.581.561.561.571.571.571.571.571.561.541.561.561.561.561.571.591.571.531.511.481.751.771.781.791.791.761.75000000
-----------------------------------------------
Details

Keystats

Revenue and Growth

The Abbott Laboratories Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Abbott Laboratories is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M USD)RECEIVABLES (M USD)OTHER REC. (M USD)INVENTORIES (M USD)OTHER CURRENT LIAB. (M USD)CURRENT ASSETS (M USD)TANGIBLE ASSETS (M USD)LONG-T. INVEST. (M USD)LONG-T. REC. (M USD)INTANGIBLE ASSETS (M USD)GOODWILL (M USD)OTHER NON-CURRENT ASSETS (M USD)NON-CURRENT ASSETS (M USD)TOTAL ASSETS (M USD)LIABILITIESCOMMON STOCK (M USD)ADDITIONAL PAID-IN CAPITAL (M USD)RETAINED EARNINGS (M USD)OTHER EQUITY (M USD)UNREAL. GAINS/LOSSES (M USD)EQUITY (M USD)LIABILITIES (M USD)PROVISIONS (M USD)OTHER SHORT-TERM LIAB. (M USD)SHORT-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)SHORT-TERM REC. (M USD)LONG-T. LIAB. (M USD)DEFERRED TAXES (M USD)OTHER LIAB. (M USD)LONG-T. LIABILITIES (M USD)DEBT (M USD)TOTAL CAPITAL (M USD)
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Abbott Laboratories provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Abbott Laboratories's financial health and stability.

Assets

Abbott Laboratories's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Abbott Laboratories must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Abbott Laboratories after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Abbott Laboratories's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B USD)DEPRECIATION (B USD)DEFERRED TAXES (M USD)CHANGES IN WORKING CAPITAL (B USD)NON-CASH ITEM (B USD)PAID INTEREST (M USD)PAID TAXES (B USD)NET CASH FLOW FROM OPERATING ACTIVITIES (B USD)CAPITAL EXPENDITURES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B USD)INTEREST INCOME AND EXPENSES (M USD)NET DEBT CHANGE (B USD)NET CHANGE IN EQUITY (M USD)CASH FLOW FROM FINANCING ACTIVITIES (B USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (USD)TOTAL DIVIDENDS PAID (M USD)NET CHANGE IN CASH FLOW (B USD)FREE CASH FLOW (M USD)SHARE-BASED COMPENSATION (M USD)
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.350.40.470.540.630.750.860.971.091.241.41.521.691.882.082.332.452.791.552.792.753.243.371.723.614.885.754.634.735.962.582.284.421.40.482.373.694.57.076.935.72
0.10.130.160.20.240.270.310.360.380.430.480.510.570.690.730.790.830.831.171.041.131.291.361.561.851.842.092.623.042.781.721.551.471.353.023.283.013.333.543.273.24
56486200000000000000000000000000000000000000
-0.050.01-0.10.02-0.01-0.09-0.21-0.11-0.06-0.28-00.16-0.34-0.24-0.29-0.34-0.33-0.45-0.64-0.14-0.42-0.510.14-0.55-1.06-0.04-0.340.660-1.86-1.24-0.49-0.16-1.511.92-0.15-1.33-0.89-0.77-1.52-2.48
-0.03-0.030.0300.020.030.01-0.010.050-0.030.030.050.050.150.090.09-0.071.490.290.291.10.32.60.791.010.151.211.582.860.530.58-2.482.270.561.281.291.521.341.591.41
0009677867494605952506790132154145113232265207198213429563561514580545576148182166181917845677549544563662
0000.150.240.360.360.340.650.70.330.570.950.80.921.060.881.090.980.880.830.680.751.280.950.770.640.811.781.371.040.450.630.620.570.740.930.971.941.861.48
0.430.560.620.760.890.970.961.21.451.391.852.211.972.382.662.883.043.13.573.993.755.115.175.335.187.347.288.748.979.313.323.682.973.25.576.36.147.910.539.587.26
-300-320-270-383-433-521-573-641-771-1,007-953-929-947-949-1,009-994-987-1,035-1,163-1,105-1,050-1,292-1,207-1,338-1,656-1,288-1,089-1,015-1,491-1,795-1,145-1,077-1,110-1,121-1,135-1,394-1,638-2,177-1,885-1,777-2,202
-300-320-270-319-528-431-392-618-642-668-794-944-1,037-1,955-1,241-1,481-1,233-617-8,384-1,690-1,631-3,923-720-11,398-1,136-2,087-3,698-12,188661-5,560-3,929-202406-248-9,618-1,356-1,815-2,215-2,008-1,740-3,133
0000.06-0.10.090.180.020.130.340.16-0.02-0.09-1.01-0.23-0.49-0.250.42-7.22-0.59-0.58-2.630.49-10.060.52-0.8-2.61-11.172.15-3.77-2.780.881.520.87-8.480.04-0.18-0.04-0.120.04-0.93
00000000000000000000000000000000000000000
0.090.11-0.180.29-0.01-0.02-0.370.35-0.110.370.12-0.10.410.840.420.38-0.86-0.675.74-1.02-0.470.810.175.65-0.54-1.243.732.12-3.984.411.790.771.1513.16-2.94-8.45-1.6-0.05-0.25-0.7-2.48
-62-46-57-468-155-116-262-554-260-534-438-580-694-699-896-809371-329152137-23-345-1,078-252191-73-317-538892-514-1,210-1,766-1,923-274-47733-420-158-2,044-3,628-1,060
-0.1-0.08-0.4-0.36-0.39-0.39-0.94-0.56-0.78-0.66-0.86-1.28-0.93-0.59-1.29-1.32-1.49-2.154.62-2.31-2.01-1.14-2.593.62-2.31-3.491-1.09-6.420.2-6.7-2.74-2.2411.15-5.28-10.39-4.29-2.78-5.49-7.64-7.09
-----------------------------400.00-521.00-6,396.00-400.00-17.00-195.00-13.00---11.00---
-122-145-167-189-219-260-301-351-410-488-548-602-653-728-809-892-1,003-1,145-1,270-1,427-1,516-1,600-1,686-1,777-1,959-2,174-2,414-2,671-2,938-3,183-882-1,342-1,443-1,539-1,849-1,974-2,270-2,560-3,202-3,309-3,556
0.030.16-0.060.08-0.020.14-0.380.020.030.060.18-0.01-0.01-0.170.130.080.290.31-0.260.050.290.231.67-2.371.941.664.7-5.163.173.99-7.330.590.9413.62-9.21-5.560.022.982.960.08-2.99
126240346.7377453444386.85606823828941,2831,018.61,4331,6511,8812,0482,063.72,403.12,886.72,6973,8163,966.93,9913,527.66,0566,186.27,720.97,4797,5192,1792,5981,8562,0824,4354,9064,4985,7248,6487,8045,059
00000000000000000000000000000000000000000

Abbott Laboratories stock margins

The Abbott Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Abbott Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Abbott Laboratories.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Abbott Laboratories's sales revenue. A higher gross margin percentage indicates that the Abbott Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Abbott Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Abbott Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Abbott Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Abbott Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Abbott Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Abbott Laboratories Margin History

Abbott Laboratories Gross marginAbbott Laboratories Profit marginAbbott Laboratories EBIT marginAbbott Laboratories Profit margin
2029e55.32 %0 %21.99 %
2028e55.32 %25.16 %20.99 %
2027e55.32 %24.57 %20.73 %
2026e55.32 %23.94 %20.59 %
2025e55.32 %23.25 %19.97 %
2024e55.32 %22.36 %19.29 %
202355.32 %16.76 %14.27 %
202256.28 %19.95 %15.88 %
202157.07 %19.94 %16.42 %
202056.75 %15.69 %12.99 %
201958.64 %14.64 %11.56 %
201858.5 %12.2 %7.74 %
201754.74 %6.83 %1.74 %
201656.43 %14.66 %6.71 %
201557.22 %14.52 %21.68 %
201454.57 %13.65 %11.28 %
201353.23 %10.85 %13.1 %
201253.29 %7.14 %31.3 %
201153 %7.4 %22.09 %
201058.3 %18.36 %13.15 %
200957.06 %21.48 %18.68 %
200857.29 %19.73 %16.53 %
200755.92 %17.67 %13.92 %
200656.33 %18.05 %7.64 %
200552.36 %19.6 %15.1 %
200454.86 %21.22 %16.44 %

Abbott Laboratories Stock Sales Revenue, EBIT, Earnings per Share

The Abbott Laboratories earnings per share therefore indicates how much revenue Abbott Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Abbott Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Abbott Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Abbott Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Abbott Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Abbott Laboratories Revenue, EBIT and net profit per share

DateAbbott Laboratories Sales per ShareAbbott Laboratories EBIT per shareAbbott Laboratories Earnings per Share
2029e35.59 USD0 USD7.83 USD
2028e31.59 USD0 USD6.63 USD
2027e29.58 USD0 USD6.13 USD
2026e27.9 USD0 USD5.74 USD
2025e26 USD0 USD5.19 USD
2024e24.23 USD0 USD4.67 USD
202322.93 USD3.84 USD3.27 USD
202224.75 USD4.94 USD3.93 USD
202124.08 USD4.8 USD3.95 USD
202019.38 USD3.04 USD2.52 USD
201917.91 USD2.62 USD2.07 USD
201817.28 USD2.11 USD1.34 USD
201715.66 USD1.07 USD0.27 USD
201614.06 USD2.06 USD0.94 USD
201513.55 USD1.97 USD2.94 USD
201413.26 USD1.81 USD1.5 USD
201312.49 USD1.36 USD1.64 USD
201211.97 USD0.85 USD3.75 USD
201113.66 USD1.01 USD3.02 USD
201022.6 USD4.15 USD2.97 USD
200919.78 USD4.25 USD3.7 USD
200818.92 USD3.73 USD3.13 USD
200716.61 USD2.94 USD2.31 USD
200614.62 USD2.64 USD1.12 USD
200514.28 USD2.8 USD2.16 USD
200412.53 USD2.66 USD2.06 USD

Abbott Laboratories business model

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories is one of the most popular companies on Eulerpool.com.

Abbott Laboratories SWOT Analysis

Strengths

Abbott Laboratories possesses several key strengths that contribute to its success in the healthcare industry. These include:

  • Strong Market Presence: As a well-established global healthcare company, Abbott Laboratories has a wide market reach and a strong brand reputation.
  • Diversified Product Portfolio: With a diverse range of healthcare products, including pharmaceuticals, diagnostics, medical devices, and nutrition, Abbott Laboratories reduces its dependence on a single product or market segment.
  • Innovation and R&D Capabilities: The company invests significantly in research and development to drive innovation and maintain a competitive edge in introducing new products and technologies.
  • Financial Stability: Abbott Laboratories has a solid financial position, reflected in its consistent revenue growth and strong profitability, allowing the company to invest in expansion and acquisitions.

Weaknesses

Despite its strengths, Abbott Laboratories is also faced with certain weaknesses that could hinder its performance. These weaknesses include:

  • Product Recalls and Quality Control Issues: The company has experienced occasional product recalls and quality control challenges, which can damage its reputation and consumer trust.
  • Dependence on Third-Party Suppliers: Abbott Laboratories relies on a network of suppliers for raw materials and components, making it vulnerable to potential disruptions, such as supply chain issues or changes in supplier relationships.
  • Regulatory Challenges: Operating in a highly regulated industry, Abbott Laboratories faces compliance challenges and increased scrutiny from regulatory authorities, which could impact its operations and product approvals.

Opportunities

Abbott Laboratories can explore various opportunities to further enhance its market position and growth potential, such as:

  • Emerging Markets: Expanding into emerging markets, where there is a growing demand for healthcare products and services, presents significant opportunities for Abbott Laboratories to increase its customer base.
  • Technological Advancements: Investing in advanced technologies and digital health solutions can help Abbott Laboratories stay ahead in the evolving healthcare landscape and provide innovative solutions to meet changing customer needs.
  • Aging Population and Chronic Diseases: With the global rise in aging population and prevalence of chronic diseases, the demand for Abbott Laboratories' healthcare products and solutions is likely to increase, creating new market opportunities.

Threats

Abbott Laboratories needs to be aware of the following threats that could potentially impact its business negatively:

  • Intense Competition: The healthcare industry is highly competitive, with numerous local and global players. Abbott Laboratories faces the risk of losing market share to competitors who offer similar healthcare products and solutions.
  • Regulatory and Legal Risks: Compliance with rigorous regulations and potential legal challenges, including product liability claims, pose threats to Abbott Laboratories, requiring proactive risk management and legal expertise.
  • Increasing Healthcare Costs: As healthcare costs continue to rise, governments and healthcare providers may exert pressure to reduce pricing, which could impact Abbott Laboratories' profitability.

Abbott Laboratories historical P/E ratio, EBIT, and P/S ratio.

Abbott Laboratories shares outstanding

The number of shares was Abbott Laboratories in 2023 — This indicates how many shares 1.749 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Abbott Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Abbott Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Abbott Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Abbott Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Abbott Laboratories Stock splits

In Abbott Laboratories's history, there have been no stock splits.

Abbott Laboratories dividend history and estimates

In 2023, Abbott Laboratories paid a dividend amounting to 2.04 USD. Dividend means that Abbott Laboratories distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Abbott Laboratories provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Abbott Laboratories’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Abbott Laboratories's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Abbott Laboratories Dividend History

DateAbbott Laboratories Dividend
2029e2.24 USD
2028e2.24 USD
2027e2.24 USD
2026e2.24 USD
2025e2.24 USD
2024e2.24 USD
20232.04 USD
20221.88 USD
20211.8 USD
20201.44 USD
20191.6 USD
20181.12 USD
20171.33 USD
20161.04 USD
20150.96 USD
20141.1 USD
20130.7 USD
20122.01 USD
20111.88 USD
20101.72 USD
20091.56 USD
20081.4 USD
20071.27 USD
20061.16 USD
20051.09 USD
20041.03 USD

Abbott Laboratories dividend payout ratio

In 2023, Abbott Laboratories had a payout ratio of 50.18%. The payout ratio indicates the percentage of the company's profits that Abbott Laboratories distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Abbott Laboratories represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Abbott Laboratories could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Abbott Laboratories's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Abbott Laboratories Payout Ratio History

DateAbbott Laboratories Payout ratio
2029e48.67 %
2028e48.66 %
2027e48.46 %
2026e48.89 %
2025e48.63 %
2024e47.86 %
202350.18 %
202247.84 %
202145.57 %
202057.14 %
201977.29 %
201884.21 %
2017490.74 %
2016110.64 %
201532.76 %
201473.83 %
201342.94 %
201253.74 %
201162.46 %
201057.91 %
200942.28 %
200845.03 %
200754.98 %
2006103.57 %
200550.23 %
200450 %
Unfortunately, there are currently no price targets and forecasts available for Abbott Laboratories.

Abbott Laboratories latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241.12 USD1.14 USD (2.22 %)2024 Q2
3/31/20240.96 USD0.98 USD (1.62 %)2024 Q1
12/31/20231.2 USD1.19 USD (-0.89 %)2023 Q4
9/30/20231.11 USD1.14 USD (2.82 %)2023 Q3
6/30/20231.06 USD1.08 USD (1.88 %)2023 Q2
3/31/20231 USD1.03 USD (3.24 %)2023 Q1
12/31/20220.93 USD1.03 USD (11.12 %)2022 Q4
9/30/20220.95 USD1.15 USD (20.61 %)2022 Q3
6/30/20221.14 USD1.43 USD (25.59 %)2022 Q2
3/31/20221.48 USD1.73 USD (16.92 %)2022 Q1
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Abbott Laboratories stock

Eulerpool World ESG Rating (EESG©)

79/ 100

🌱 Environment

74

👫 Social

81

🏛️ Governance

82

Environment

Scope 1 - Direct Emissions
533,000
Scope 2 - Indirect emissions from purchased energy
478,000
Scope 3 - Indirect emissions within the value chain
12,480,000
Total CO₂ emissions
1,010,000
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees45
Percentage of women in management
Percentage of Asian employees19.27
Share of Asian management
Percentage of Hispanic/Latino employees10.91
Hispano/Latino Management share
Percentage of Black employees8.99
Black Management Share
Percentage of white employees57.82
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Abbott Laboratories list of shareholders

%
Name
Stocks
Change
Date
8.95 % The Vanguard Group, Inc.155,722,778690,39712/31/2023
4.98 % Capital Research Global Investors86,588,6147,527,77812/31/2023
4.96 % BlackRock Institutional Trust Company, N.A.86,299,820-3,046,48512/31/2023
4.29 % State Street Global Advisors (US)74,687,1761,453,96912/31/2023
3.70 % Capital International Investors64,294,7841,457,84712/31/2023
1.89 % Geode Capital Management, L.L.C.32,853,400429,98112/31/2023
1.85 % Wellington Management Company, LLP32,236,1011,027,39012/31/2023
1.10 % Norges Bank Investment Management (NBIM)19,222,6371,974,11512/31/2023
0.85 % Wells Fargo Advisors14,859,170-135,74612/31/2023
0.82 % Legal & General Investment Management Ltd.14,299,2501,873,41112/31/2023
1
2
3
4
5
...
10

Abbott Laboratories Executives and Management Board

Mr. Robert Ford49
Abbott Laboratories Chairman of the Board, Chief Executive Officer (since 2014)
Compensation 21.72 M USD
Mr. Robert Funck61
Abbott Laboratories Executive Vice President - Finance
Compensation 9.15 M USD
Ms. Lisa Earnhardt53
Abbott Laboratories Executive Vice President - Medical Devices
Compensation 7.48 M USD
Mr. Daniel Salvadori44
Abbott Laboratories Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Compensation 7.16 M USD
Mr. Hubert Allen57
Abbott Laboratories Executive Vice President, General Counsel, Secretary
Compensation 7.02 M USD
1
2
3
4
5
...
7

Abbott Laboratories Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer-0,400,490,870,560,76
Apria, Inc. Stock
Apria, Inc.
SupplierCustomer--0,14-0,62-0,55-0,19-
SupplierCustomer0,960,890,870,720,150,61
SupplierCustomer0,93-0,01-0,520,140,070,19
SupplierCustomer0,890,340,280,66-0,09-0,15
SupplierCustomer0,870,360,300,710,550,74
SupplierCustomer0,860,910,920,840,190,41
SupplierCustomer0,820,840,330,670,230,37
SupplierCustomer0,810,690,850,91-0,16-
SupplierCustomer0,810,360,740,850,230,68
1
2
3
4
5
...
12

Most common questions regarding Abbott Laboratories

What values and corporate philosophy does Abbott Laboratories represent?

Abbott Laboratories is committed to its core values of putting patients first, serving customers with innovative solutions, and operating with integrity in all aspects of its business. The company's corporate philosophy centers around improving life through the development of groundbreaking technologies and products. Abbott Laboratories prides itself on its dedication to delivering reliable healthcare solutions, fostering collaboration with healthcare professionals, and investing in research and development to address unmet medical needs. With a focus on providing high-quality and accessible healthcare options, Abbott Laboratories strives to create positive impacts in communities worldwide through its diverse portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.

In which countries and regions is Abbott Laboratories primarily present?

Abbott Laboratories is primarily present in multiple countries and regions worldwide. The company operates in more than 160 countries, including the United States, Canada, Europe, Asia-Pacific, Latin America, and the Middle East. With a strong global footprint, Abbott Laboratories has established itself as a leading healthcare company in various markets, delivering innovative medical products, diagnostics, nutritionals, and pharmaceuticals to improve people's health and well-being.

What significant milestones has the company Abbott Laboratories achieved?

Abbott Laboratories has achieved several significant milestones throughout its history. One major milestone was the development and commercialization of the first-ever HIV blood screening test, which greatly contributed to safer transfusions and the prevention of the spread of HIV. Additionally, Abbott Laboratories introduced breakthrough medical devices, such as the FreeStyle® Libre system, a continuous glucose monitoring system for diabetes management. The company also played a crucial role in the fight against COVID-19 by developing rapid diagnostic tests for the virus. Furthermore, Abbott Laboratories has consistently been recognized for its commitment to innovation and sustainability, making it a leading healthcare company globally.

What is the history and background of the company Abbott Laboratories?

Abbott Laboratories is a renowned American healthcare company, known for providing a diverse range of medical, pharmaceutical, and nutritional products. Founded in 1888 by Dr. Wallace C. Abbott, the company initially focused on producing pharmaceuticals, including the widely successful alkaloid-based pain reliever, Abbott's ABC Liniment. Over the years, Abbott Laboratories has expanded its portfolio, venturing into areas such as diagnostics, medical devices, and nutrition. The company's commitment to innovation is evident through breakthroughs like the development of the first HIV blood-screening test. Today, Abbott Laboratories continues to play a crucial role in improving health outcomes worldwide, with its cutting-edge technology and a focus on delivering quality healthcare solutions.

Who are the main competitors of Abbott Laboratories in the market?

The main competitors of Abbott Laboratories in the market are Johnson & Johnson, Pfizer, and Roche Holding AG.

In which industries is Abbott Laboratories primarily active?

Abbott Laboratories is primarily active in the healthcare industry.

What is the business model of Abbott Laboratories?

Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.

What is the P/E ratio of Abbott Laboratories 2024?

The Abbott Laboratories P/E ratio is 22.31.

What is the P/S ratio of Abbott Laboratories 2024?

The Abbott Laboratories P/S ratio is 4.3.

What is the AlleAktien quality score of Abbott Laboratories?

The AlleAktien quality score for Abbott Laboratories is 7/10.

What is the revenue of Abbott Laboratories 2024?

The expected Abbott Laboratories revenue is 42.16 B USD.

How high is the profit of Abbott Laboratories 2024?

The expected Abbott Laboratories profit is 8.13 B USD.

What is the business model of Abbott Laboratories

Abbott Laboratories is a global company specializing in the development, manufacturing, and marketing of health products and services. Its business model is divided into different divisions that focus on the needs of patients, doctors, and healthcare systems. The divisions of Abbott Laboratories include Diagnostics, Medical Devices, Nutrition, and Pharmaceutical. The company aims to continuously develop innovative technologies and products to improve healthcare, and it offers a wide range of services and support programs for patients. Abbott Laboratories has established a strong market position and global presence in over 160 countries since its establishment in 1888. It also pursues a successful acquisition strategy to expand its product portfolio, such as the acquisition of St. Jude Medical in 2017 to enhance its cardiovascular products and services. Overall, Abbott Laboratories aims to improve healthcare and meet the needs of patients, doctors, and healthcare systems through its comprehensive strategy focused on developing innovative products, expanding into new markets, and increasing efficiency.

What is the Abbott Laboratories dividend?

Abbott Laboratories pays a dividend of 1.88 USD distributed over 4 payouts per year.

How often does Abbott Laboratories pay dividends?

Abbott Laboratories pays out a dividend 4 times a year.

What is the Abbott Laboratories ISIN?

The ISIN of Abbott Laboratories is US0028241000.

What is the Abbott Laboratories WKN?

The WKN of Abbott Laboratories is 850103.

What is the Abbott Laboratories ticker?

The ticker of Abbott Laboratories is ABT.

How much dividend does Abbott Laboratories pay?

Over the past 12 months, Abbott Laboratories paid a dividend of 2.04 USD . This corresponds to a dividend yield of about 1.97 %. For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.24 USD.

What is the dividend yield of Abbott Laboratories?

The current dividend yield of Abbott Laboratories is 1.97 %.

When does Abbott Laboratories pay dividends?

Abbott Laboratories pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Abbott Laboratories?

Abbott Laboratories paid dividends every year for the past 26 years.

What is the dividend of Abbott Laboratories?

For the upcoming 12 months, dividends amounting to 2.24 USD are expected. This corresponds to a dividend yield of 2.16 %.

In which sector is Abbott Laboratories located?

Abbott Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbott Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbott Laboratories from 8/15/2024 amounting to 0.55 USD, you needed to have the stock in your portfolio before the ex-date on 7/15/2024.

When did Abbott Laboratories pay the last dividend?

The last dividend was paid out on 8/15/2024.

What was the dividend of Abbott Laboratories in the year 2023?

In the year 2023, Abbott Laboratories distributed 1.88 USD as dividends.

In which currency does Abbott Laboratories pay out the dividend?

The dividends of Abbott Laboratories are distributed in USD.

All fundamentals about Abbott Laboratories

Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.